Jan Alfheim

Biography

Mr. Jan A. Alfheim has served as served as Chief Operating Officer at NORDIC NANOVECTOR ASA since September 1, 2014. He was Chief Executive Officer (CEO) of Nordic Nanovector ASA from August 2011 until September 1, 2014. He has 30 years of experience in the healthcare and chemical industries. Before joining Nordic Nanovector, he worked for the Norwegian cancer drug development company, Clavis Pharma ASA, as Chief Business Officer and Member of the Senior Management Team. Prior to joining Clavis, he spent seven years in Canada, first as Director of Business Development at Neurochem Inc and as President of Stempath Inc. He holds a Master of Science degree in Chemistry from Concordia University from 1985 and a Master of Business Administration degree from McGill University in Montreal from 2002.

Research Interest

Nanomedicine Design of Nanodrugs Personalized Nanomedicine Nanomaterials for drug delivery